Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Eko Analysis Software

K-Number: K192004 · 2020-01-15

Decision Date2020-01-15
Product CodeMWI
Advisory CommitteeCV
DecisionSubstantially Equivalent

Device Summary

Eko Analysis Software is a medical device manufactured by Eko Devices, Inc.. It received FDA 510(k) clearance on 2020-01-15 under approval number K192004. The device is classified under product code MWI. It was reviewed by the CV advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Eko Analysis Software?

Eko Analysis Software is a medical device that received FDA 510(k) clearance on 2020-01-15. It is manufactured by Eko Devices, Inc.. The 510(k) number is K192004.

When was Eko Analysis Software approved by the FDA?

Eko Analysis Software received FDA 510(k) clearance on 2020-01-15, under approval number K192004.

What company makes Eko Analysis Software?

Eko Analysis Software is manufactured by Eko Devices, Inc..

What is the FDA product code for Eko Analysis Software?

The FDA product code for Eko Analysis Software is MWI.

Related Clinical Trials

Related PubMed Literature

Other Devices by Eko Devices, Inc.

Related Devices (Code: MWI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.